nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimipramine—ABCB1—hematologic cancer	0.0735	1	CbGaD
Trimipramine—CYP2C9—Bexarotene—hematologic cancer	0.0199	0.0366	CbGbCtD
Trimipramine—ABCB1—Lenalidomide—hematologic cancer	0.0193	0.0356	CbGbCtD
Trimipramine—CYP2D6—Lomustine—hematologic cancer	0.0169	0.0311	CbGbCtD
Trimipramine—CYP2C9—Idarubicin—hematologic cancer	0.0165	0.0304	CbGbCtD
Trimipramine—CYP2D6—Idarubicin—hematologic cancer	0.0151	0.0278	CbGbCtD
Trimipramine—CYP2C19—Bortezomib—hematologic cancer	0.0147	0.027	CbGbCtD
Trimipramine—CYP2D6—Hydroxyurea—hematologic cancer	0.0128	0.0236	CbGbCtD
Trimipramine—CYP2C19—Thalidomide—hematologic cancer	0.0128	0.0235	CbGbCtD
Trimipramine—CYP2C9—Bortezomib—hematologic cancer	0.0122	0.0225	CbGbCtD
Trimipramine—CYP2C19—Teniposide—hematologic cancer	0.0122	0.0224	CbGbCtD
Trimipramine—CYP3A4—Bexarotene—hematologic cancer	0.0116	0.0213	CbGbCtD
Trimipramine—ABCB1—Daunorubicin—hematologic cancer	0.0113	0.0208	CbGbCtD
Trimipramine—CYP2C19—Ifosfamide—hematologic cancer	0.0113	0.0207	CbGbCtD
Trimipramine—CYP2D6—Bortezomib—hematologic cancer	0.0112	0.0205	CbGbCtD
Trimipramine—ABCB1—Alitretinoin—hematologic cancer	0.0111	0.0204	CbGbCtD
Trimipramine—CYP3A4—Busulfan—hematologic cancer	0.0108	0.0198	CbGbCtD
Trimipramine—CYP3A4—Lomustine—hematologic cancer	0.0108	0.0198	CbGbCtD
Trimipramine—CYP2C19—Imatinib—hematologic cancer	0.0108	0.0198	CbGbCtD
Trimipramine—CYP2C9—Thalidomide—hematologic cancer	0.0106	0.0196	CbGbCtD
Trimipramine—CYP2C9—Teniposide—hematologic cancer	0.0101	0.0187	CbGbCtD
Trimipramine—CYP3A4—Thiotepa—hematologic cancer	0.0096	0.0177	CbGbCtD
Trimipramine—CYP2C9—Ifosfamide—hematologic cancer	0.00937	0.0172	CbGbCtD
Trimipramine—CYP2C9—Imatinib—hematologic cancer	0.00895	0.0165	CbGbCtD
Trimipramine—ABCB1—Imatinib—hematologic cancer	0.00868	0.016	CbGbCtD
Trimipramine—CYP2D6—Imatinib—hematologic cancer	0.00818	0.015	CbGbCtD
Trimipramine—CYP2C9—Nilotinib—hematologic cancer	0.00813	0.0149	CbGbCtD
Trimipramine—ABCB1—Nilotinib—hematologic cancer	0.00789	0.0145	CbGbCtD
Trimipramine—ABCB1—Vinorelbine—hematologic cancer	0.00782	0.0144	CbGbCtD
Trimipramine—CYP3A4—Methoxsalen—hematologic cancer	0.00747	0.0137	CbGbCtD
Trimipramine—CYP2D6—Nilotinib—hematologic cancer	0.00744	0.0137	CbGbCtD
Trimipramine—CYP2D6—Vinorelbine—hematologic cancer	0.00737	0.0136	CbGbCtD
Trimipramine—CYP3A4—Bortezomib—hematologic cancer	0.0071	0.0131	CbGbCtD
Trimipramine—CYP2C19—Prednisone—hematologic cancer	0.00709	0.013	CbGbCtD
Trimipramine—ABCB1—Dasatinib—hematologic cancer	0.00697	0.0128	CbGbCtD
Trimipramine—ABCB1—Mitoxantrone—hematologic cancer	0.00689	0.0127	CbGbCtD
Trimipramine—CYP3A4—Daunorubicin—hematologic cancer	0.00679	0.0125	CbGbCtD
Trimipramine—ABCB1—Betamethasone—hematologic cancer	0.00614	0.0113	CbGbCtD
Trimipramine—ABCB1—Gemcitabine—hematologic cancer	0.00609	0.0112	CbGbCtD
Trimipramine—ABCB1—Prednisolone—hematologic cancer	0.00606	0.0111	CbGbCtD
Trimipramine—CYP3A4—Cytarabine—hematologic cancer	0.00599	0.011	CbGbCtD
Trimipramine—CYP3A4—Teniposide—hematologic cancer	0.0059	0.0109	CbGbCtD
Trimipramine—ABCB1—Prednisone—hematologic cancer	0.00572	0.0105	CbGbCtD
Trimipramine—CYP3A4—Ifosfamide—hematologic cancer	0.00545	0.01	CbGbCtD
Trimipramine—ABCB1—Irinotecan—hematologic cancer	0.00542	0.00997	CbGbCtD
Trimipramine—CYP3A4—Imatinib—hematologic cancer	0.0052	0.00957	CbGbCtD
Trimipramine—CYP3A4—Ruxolitinib—hematologic cancer	0.0049	0.00901	CbGbCtD
Trimipramine—ABCB1—Vinblastine—hematologic cancer	0.00482	0.00887	CbGbCtD
Trimipramine—ABCB1—Vincristine—hematologic cancer	0.00474	0.00872	CbGbCtD
Trimipramine—CYP3A4—Nilotinib—hematologic cancer	0.00473	0.00869	CbGbCtD
Trimipramine—CYP3A4—Vinorelbine—hematologic cancer	0.00469	0.00862	CbGbCtD
Trimipramine—CYP2C9—Cisplatin—hematologic cancer	0.00456	0.00838	CbGbCtD
Trimipramine—CYP2D6—Vinblastine—hematologic cancer	0.00454	0.00835	CbGbCtD
Trimipramine—CYP2C19—Dexamethasone—hematologic cancer	0.00443	0.00814	CbGbCtD
Trimipramine—ABCB1—Cisplatin—hematologic cancer	0.00442	0.00813	CbGbCtD
Trimipramine—ABCB1—Etoposide—hematologic cancer	0.00434	0.00799	CbGbCtD
Trimipramine—CYP3A4—Triamcinolone—hematologic cancer	0.00429	0.00788	CbGbCtD
Trimipramine—CYP3A4—Dasatinib—hematologic cancer	0.00418	0.00768	CbGbCtD
Trimipramine—CYP3A4—Mitoxantrone—hematologic cancer	0.00413	0.00759	CbGbCtD
Trimipramine—CYP2C9—Dexamethasone—hematologic cancer	0.00368	0.00677	CbGbCtD
Trimipramine—CYP3A4—Betamethasone—hematologic cancer	0.00368	0.00676	CbGbCtD
Trimipramine—CYP3A4—Prednisolone—hematologic cancer	0.00363	0.00667	CbGbCtD
Trimipramine—ABCB1—Dexamethasone—hematologic cancer	0.00357	0.00657	CbGbCtD
Trimipramine—CYP3A4—Prednisone—hematologic cancer	0.00343	0.0063	CbGbCtD
Trimipramine—CYP2D6—Dexamethasone—hematologic cancer	0.00337	0.00619	CbGbCtD
Trimipramine—CYP3A4—Irinotecan—hematologic cancer	0.00325	0.00597	CbGbCtD
Trimipramine—ABCB1—Doxorubicin—hematologic cancer	0.00296	0.00545	CbGbCtD
Trimipramine—CYP3A4—Vinblastine—hematologic cancer	0.00289	0.00531	CbGbCtD
Trimipramine—ABCB1—Methotrexate—hematologic cancer	0.00287	0.00528	CbGbCtD
Trimipramine—CYP3A4—Vincristine—hematologic cancer	0.00284	0.00522	CbGbCtD
Trimipramine—CYP2D6—Doxorubicin—hematologic cancer	0.00279	0.00513	CbGbCtD
Trimipramine—CYP3A4—Etoposide—hematologic cancer	0.0026	0.00479	CbGbCtD
Trimipramine—CYP3A4—Dexamethasone—hematologic cancer	0.00214	0.00393	CbGbCtD
Trimipramine—CYP3A4—Doxorubicin—hematologic cancer	0.00178	0.00326	CbGbCtD
Trimipramine—HTR3A—hematopoietic system—hematologic cancer	0.00111	0.0535	CbGeAlD
Trimipramine—SLC6A3—hematopoietic system—hematologic cancer	0.000925	0.0445	CbGeAlD
Trimipramine—SLC6A4—hematopoietic system—hematologic cancer	0.000848	0.0408	CbGeAlD
Trimipramine—HTR1A—hematopoietic system—hematologic cancer	0.000753	0.0362	CbGeAlD
Trimipramine—HTR3A—blood—hematologic cancer	0.000737	0.0354	CbGeAlD
Trimipramine—CYP2C19—hematopoietic system—hematologic cancer	0.000703	0.0338	CbGeAlD
Trimipramine—ADRA1A—hematopoietic system—hematologic cancer	0.000694	0.0334	CbGeAlD
Trimipramine—HTR3A—lung—hematologic cancer	0.000646	0.031	CbGeAlD
Trimipramine—SLC6A2—gonad—hematologic cancer	0.000568	0.0273	CbGeAlD
Trimipramine—SLC6A4—blood—hematologic cancer	0.000562	0.027	CbGeAlD
Trimipramine—CYP2C9—hematopoietic system—hematologic cancer	0.000545	0.0262	CbGeAlD
Trimipramine—SLC6A3—lung—hematologic cancer	0.000537	0.0258	CbGeAlD
Trimipramine—HRH1—hematopoietic system—hematologic cancer	0.000537	0.0258	CbGeAlD
Trimipramine—ADRA2A—hematopoietic system—hematologic cancer	0.000528	0.0254	CbGeAlD
Trimipramine—SLC6A3—testis—hematologic cancer	0.000507	0.0244	CbGeAlD
Trimipramine—SLC6A4—lung—hematologic cancer	0.000493	0.0237	CbGeAlD
Trimipramine—CYP2C19—blood—hematologic cancer	0.000466	0.0224	CbGeAlD
Trimipramine—ADRA1A—blood—hematologic cancer	0.00046	0.0221	CbGeAlD
Trimipramine—HTR2A—hematopoietic system—hematologic cancer	0.000449	0.0216	CbGeAlD
Trimipramine—SLC6A2—lung—hematologic cancer	0.000434	0.0208	CbGeAlD
Trimipramine—CYP3A4—hematopoietic system—hematologic cancer	0.000415	0.02	CbGeAlD
Trimipramine—SLC6A2—testis—hematologic cancer	0.000409	0.0197	CbGeAlD
Trimipramine—CYP2D6—hematopoietic system—hematologic cancer	0.000409	0.0196	CbGeAlD
Trimipramine—ADRA2A—gonad—hematologic cancer	0.000401	0.0193	CbGeAlD
Trimipramine—DRD2—lung—hematologic cancer	0.000395	0.019	CbGeAlD
Trimipramine—DRD2—testis—hematologic cancer	0.000373	0.0179	CbGeAlD
Trimipramine—CYP2C9—blood—hematologic cancer	0.000361	0.0173	CbGeAlD
Trimipramine—ADRA2A—blood—hematologic cancer	0.00035	0.0168	CbGeAlD
Trimipramine—HTR2A—gonad—hematologic cancer	0.000341	0.0164	CbGeAlD
Trimipramine—Benazepril—MTHFR—hematologic cancer	0.000332	0.17	CrCbGaD
Trimipramine—HRH1—lung—hematologic cancer	0.000312	0.015	CbGeAlD
Trimipramine—ADRA2A—lung—hematologic cancer	0.000307	0.0147	CbGeAlD
Trimipramine—HTR2A—blood—hematologic cancer	0.000297	0.0143	CbGeAlD
Trimipramine—SLC6A2—lymph node—hematologic cancer	0.000297	0.0143	CbGeAlD
Trimipramine—HRH1—testis—hematologic cancer	0.000294	0.0142	CbGeAlD
Trimipramine—ABCB1—hematopoietic system—hematologic cancer	0.000294	0.0141	CbGeAlD
Trimipramine—ADRA2A—testis—hematologic cancer	0.000289	0.0139	CbGeAlD
Trimipramine—CYP3A4—blood—hematologic cancer	0.000275	0.0132	CbGeAlD
Trimipramine—CYP2D6—blood—hematologic cancer	0.000271	0.013	CbGeAlD
Trimipramine—HTR2A—lung—hematologic cancer	0.000261	0.0125	CbGeAlD
Trimipramine—HTR2A—testis—hematologic cancer	0.000246	0.0118	CbGeAlD
Trimipramine—CYP2D6—testis—hematologic cancer	0.000224	0.0108	CbGeAlD
Trimipramine—ABCB1—gonad—hematologic cancer	0.000224	0.0107	CbGeAlD
Trimipramine—HRH1—lymph node—hematologic cancer	0.000213	0.0103	CbGeAlD
Trimipramine—ADRA2A—lymph node—hematologic cancer	0.00021	0.0101	CbGeAlD
Trimipramine—Acepromazine—SLC22A1—hematologic cancer	0.000209	0.107	CrCbGaD
Trimipramine—ABCB1—blood—hematologic cancer	0.000195	0.00936	CbGeAlD
Trimipramine—ABCB1—bone marrow—hematologic cancer	0.000189	0.00906	CbGeAlD
Trimipramine—Clomipramine—GSTP1—hematologic cancer	0.000172	0.088	CrCbGaD
Trimipramine—ABCB1—lung—hematologic cancer	0.000171	0.00821	CbGeAlD
Trimipramine—ABCB1—testis—hematologic cancer	0.000161	0.00775	CbGeAlD
Trimipramine—Diphenhydramine—SLC22A1—hematologic cancer	0.000143	0.0735	CrCbGaD
Trimipramine—Desipramine—SLC22A1—hematologic cancer	0.000128	0.0655	CrCbGaD
Trimipramine—ABCB1—lymph node—hematologic cancer	0.000117	0.00561	CbGeAlD
Trimipramine—Chlorpromazine—SLC22A1—hematologic cancer	0.000109	0.0558	CrCbGaD
Trimipramine—Imipramine—SLC22A1—hematologic cancer	0.000108	0.0555	CrCbGaD
Trimipramine—Epinastine—ABCB1—hematologic cancer	8.72e-05	0.0447	CrCbGaD
Trimipramine—Oxcarbazepine—ALB—hematologic cancer	8.42e-05	0.0432	CrCbGaD
Trimipramine—Acepromazine—ALB—hematologic cancer	6.36e-05	0.0326	CrCbGaD
Trimipramine—Carbamazepine—ABCB1—hematologic cancer	5.48e-05	0.0281	CrCbGaD
Trimipramine—Nausea—Thalidomide—hematologic cancer	5.37e-05	0.000211	CcSEcCtD
Trimipramine—Dyspepsia—Triamcinolone—hematologic cancer	5.36e-05	0.000211	CcSEcCtD
Trimipramine—Rash—Ifosfamide—hematologic cancer	5.36e-05	0.000211	CcSEcCtD
Trimipramine—Dermatitis—Ifosfamide—hematologic cancer	5.35e-05	0.00021	CcSEcCtD
Trimipramine—Neuropathy peripheral—Doxorubicin—hematologic cancer	5.35e-05	0.00021	CcSEcCtD
Trimipramine—Dizziness—Irinotecan—hematologic cancer	5.34e-05	0.00021	CcSEcCtD
Trimipramine—Urticaria—Etoposide—hematologic cancer	5.33e-05	0.00021	CcSEcCtD
Trimipramine—Jaundice—Doxorubicin—hematologic cancer	5.32e-05	0.000209	CcSEcCtD
Trimipramine—Stomatitis—Doxorubicin—hematologic cancer	5.32e-05	0.000209	CcSEcCtD
Trimipramine—Malaise—Prednisone—hematologic cancer	5.32e-05	0.000209	CcSEcCtD
Trimipramine—Body temperature increased—Etoposide—hematologic cancer	5.31e-05	0.000209	CcSEcCtD
Trimipramine—Abdominal pain—Etoposide—hematologic cancer	5.31e-05	0.000209	CcSEcCtD
Trimipramine—Tinnitus—Methotrexate—hematologic cancer	5.28e-05	0.000207	CcSEcCtD
Trimipramine—Hypoaesthesia—Epirubicin—hematologic cancer	5.27e-05	0.000207	CcSEcCtD
Trimipramine—Vomiting—Vincristine—hematologic cancer	5.27e-05	0.000207	CcSEcCtD
Trimipramine—Anorexia—Dexamethasone—hematologic cancer	5.27e-05	0.000207	CcSEcCtD
Trimipramine—Anorexia—Betamethasone—hematologic cancer	5.27e-05	0.000207	CcSEcCtD
Trimipramine—Urticaria—Prednisolone—hematologic cancer	5.26e-05	0.000207	CcSEcCtD
Trimipramine—Asthenia—Cisplatin—hematologic cancer	5.26e-05	0.000207	CcSEcCtD
Trimipramine—Fatigue—Triamcinolone—hematologic cancer	5.25e-05	0.000206	CcSEcCtD
Trimipramine—Rash—Vincristine—hematologic cancer	5.23e-05	0.000205	CcSEcCtD
Trimipramine—Dermatitis—Vincristine—hematologic cancer	5.22e-05	0.000205	CcSEcCtD
Trimipramine—Headache—Vincristine—hematologic cancer	5.19e-05	0.000204	CcSEcCtD
Trimipramine—Hypotension—Dexamethasone—hematologic cancer	5.16e-05	0.000203	CcSEcCtD
Trimipramine—Hypotension—Betamethasone—hematologic cancer	5.16e-05	0.000203	CcSEcCtD
Trimipramine—Nausea—Carmustine—hematologic cancer	5.16e-05	0.000203	CcSEcCtD
Trimipramine—Vomiting—Irinotecan—hematologic cancer	5.13e-05	0.000202	CcSEcCtD
Trimipramine—Vomiting—Mitoxantrone—hematologic cancer	5.13e-05	0.000202	CcSEcCtD
Trimipramine—Nausea—Alitretinoin—hematologic cancer	5.11e-05	0.000201	CcSEcCtD
Trimipramine—Convulsion—Prednisone—hematologic cancer	5.11e-05	0.000201	CcSEcCtD
Trimipramine—Agranulocytosis—Doxorubicin—hematologic cancer	5.09e-05	0.0002	CcSEcCtD
Trimipramine—Hypertension—Prednisone—hematologic cancer	5.09e-05	0.0002	CcSEcCtD
Trimipramine—Rash—Mitoxantrone—hematologic cancer	5.09e-05	0.0002	CcSEcCtD
Trimipramine—Rash—Irinotecan—hematologic cancer	5.09e-05	0.0002	CcSEcCtD
Trimipramine—Dermatitis—Irinotecan—hematologic cancer	5.08e-05	0.0002	CcSEcCtD
Trimipramine—Dermatitis—Mitoxantrone—hematologic cancer	5.08e-05	0.0002	CcSEcCtD
Trimipramine—Headache—Irinotecan—hematologic cancer	5.06e-05	0.000199	CcSEcCtD
Trimipramine—Headache—Mitoxantrone—hematologic cancer	5.06e-05	0.000199	CcSEcCtD
Trimipramine—Nausea—Ifosfamide—hematologic cancer	5.05e-05	0.000198	CcSEcCtD
Trimipramine—Feeling abnormal—Triamcinolone—hematologic cancer	5.02e-05	0.000197	CcSEcCtD
Trimipramine—Diarrhoea—Cisplatin—hematologic cancer	5.01e-05	0.000197	CcSEcCtD
Trimipramine—Anxiety—Prednisone—hematologic cancer	5e-05	0.000197	CcSEcCtD
Trimipramine—Alopecia—Methotrexate—hematologic cancer	5e-05	0.000197	CcSEcCtD
Trimipramine—Vomiting—Gemcitabine—hematologic cancer	5e-05	0.000196	CcSEcCtD
Trimipramine—Insomnia—Betamethasone—hematologic cancer	5e-05	0.000196	CcSEcCtD
Trimipramine—Insomnia—Dexamethasone—hematologic cancer	5e-05	0.000196	CcSEcCtD
Trimipramine—Paraesthesia—Dexamethasone—hematologic cancer	4.96e-05	0.000195	CcSEcCtD
Trimipramine—Paraesthesia—Betamethasone—hematologic cancer	4.96e-05	0.000195	CcSEcCtD
Trimipramine—Discomfort—Prednisone—hematologic cancer	4.96e-05	0.000195	CcSEcCtD
Trimipramine—Rash—Gemcitabine—hematologic cancer	4.96e-05	0.000195	CcSEcCtD
Trimipramine—Dermatitis—Gemcitabine—hematologic cancer	4.95e-05	0.000195	CcSEcCtD
Trimipramine—Tinnitus—Epirubicin—hematologic cancer	4.94e-05	0.000194	CcSEcCtD
Trimipramine—Headache—Gemcitabine—hematologic cancer	4.93e-05	0.000194	CcSEcCtD
Trimipramine—Nausea—Vincristine—hematologic cancer	4.92e-05	0.000193	CcSEcCtD
Trimipramine—Flushing—Epirubicin—hematologic cancer	4.92e-05	0.000193	CcSEcCtD
Trimipramine—Hypoaesthesia—Doxorubicin—hematologic cancer	4.88e-05	0.000192	CcSEcCtD
Trimipramine—Dyspepsia—Dexamethasone—hematologic cancer	4.86e-05	0.000191	CcSEcCtD
Trimipramine—Dyspepsia—Betamethasone—hematologic cancer	4.86e-05	0.000191	CcSEcCtD
Trimipramine—Urticaria—Triamcinolone—hematologic cancer	4.84e-05	0.00019	CcSEcCtD
Trimipramine—Clomipramine—ALB—hematologic cancer	4.84e-05	0.0248	CrCbGaD
Trimipramine—Dysgeusia—Methotrexate—hematologic cancer	4.83e-05	0.00019	CcSEcCtD
Trimipramine—Asthenia—Etoposide—hematologic cancer	4.82e-05	0.000189	CcSEcCtD
Trimipramine—Body temperature increased—Triamcinolone—hematologic cancer	4.81e-05	0.000189	CcSEcCtD
Trimipramine—Oedema—Prednisone—hematologic cancer	4.81e-05	0.000189	CcSEcCtD
Trimipramine—Decreased appetite—Dexamethasone—hematologic cancer	4.8e-05	0.000189	CcSEcCtD
Trimipramine—Decreased appetite—Betamethasone—hematologic cancer	4.8e-05	0.000189	CcSEcCtD
Trimipramine—Nausea—Mitoxantrone—hematologic cancer	4.79e-05	0.000188	CcSEcCtD
Trimipramine—Nausea—Irinotecan—hematologic cancer	4.79e-05	0.000188	CcSEcCtD
Trimipramine—Fatigue—Dexamethasone—hematologic cancer	4.76e-05	0.000187	CcSEcCtD
Trimipramine—Fatigue—Betamethasone—hematologic cancer	4.76e-05	0.000187	CcSEcCtD
Trimipramine—Pruritus—Etoposide—hematologic cancer	4.75e-05	0.000187	CcSEcCtD
Trimipramine—Arrhythmia—Epirubicin—hematologic cancer	4.73e-05	0.000186	CcSEcCtD
Trimipramine—Nortriptyline—ALB—hematologic cancer	4.73e-05	0.0242	CrCbGaD
Trimipramine—Tachycardia—Prednisone—hematologic cancer	4.7e-05	0.000185	CcSEcCtD
Trimipramine—Alopecia—Epirubicin—hematologic cancer	4.68e-05	0.000184	CcSEcCtD
Trimipramine—Nausea—Gemcitabine—hematologic cancer	4.67e-05	0.000184	CcSEcCtD
Trimipramine—Vomiting—Cisplatin—hematologic cancer	4.66e-05	0.000183	CcSEcCtD
Trimipramine—Vision blurred—Methotrexate—hematologic cancer	4.64e-05	0.000183	CcSEcCtD
Trimipramine—Rash—Cisplatin—hematologic cancer	4.62e-05	0.000182	CcSEcCtD
Trimipramine—Dermatitis—Cisplatin—hematologic cancer	4.62e-05	0.000181	CcSEcCtD
Trimipramine—Clomipramine—ABCB1—hematologic cancer	4.62e-05	0.0237	CrCbGaD
Trimipramine—Diarrhoea—Etoposide—hematologic cancer	4.59e-05	0.000181	CcSEcCtD
Trimipramine—Anorexia—Prednisone—hematologic cancer	4.59e-05	0.00018	CcSEcCtD
Trimipramine—Ill-defined disorder—Methotrexate—hematologic cancer	4.57e-05	0.00018	CcSEcCtD
Trimipramine—Tinnitus—Doxorubicin—hematologic cancer	4.57e-05	0.00018	CcSEcCtD
Trimipramine—Feeling abnormal—Betamethasone—hematologic cancer	4.55e-05	0.000179	CcSEcCtD
Trimipramine—Feeling abnormal—Dexamethasone—hematologic cancer	4.55e-05	0.000179	CcSEcCtD
Trimipramine—Flushing—Doxorubicin—hematologic cancer	4.55e-05	0.000179	CcSEcCtD
Trimipramine—Dysgeusia—Epirubicin—hematologic cancer	4.52e-05	0.000177	CcSEcCtD
Trimipramine—Malaise—Methotrexate—hematologic cancer	4.44e-05	0.000175	CcSEcCtD
Trimipramine—Dizziness—Etoposide—hematologic cancer	4.44e-05	0.000175	CcSEcCtD
Trimipramine—Urticaria—Betamethasone—hematologic cancer	4.39e-05	0.000173	CcSEcCtD
Trimipramine—Urticaria—Dexamethasone—hematologic cancer	4.39e-05	0.000173	CcSEcCtD
Trimipramine—Dizziness—Prednisolone—hematologic cancer	4.38e-05	0.000172	CcSEcCtD
Trimipramine—Arrhythmia—Doxorubicin—hematologic cancer	4.38e-05	0.000172	CcSEcCtD
Trimipramine—Asthenia—Triamcinolone—hematologic cancer	4.37e-05	0.000172	CcSEcCtD
Trimipramine—Body temperature increased—Betamethasone—hematologic cancer	4.37e-05	0.000172	CcSEcCtD
Trimipramine—Abdominal pain—Dexamethasone—hematologic cancer	4.37e-05	0.000172	CcSEcCtD
Trimipramine—Body temperature increased—Dexamethasone—hematologic cancer	4.37e-05	0.000172	CcSEcCtD
Trimipramine—Abdominal pain—Betamethasone—hematologic cancer	4.37e-05	0.000172	CcSEcCtD
Trimipramine—Nausea—Cisplatin—hematologic cancer	4.35e-05	0.000171	CcSEcCtD
Trimipramine—Insomnia—Prednisone—hematologic cancer	4.35e-05	0.000171	CcSEcCtD
Trimipramine—Vision blurred—Epirubicin—hematologic cancer	4.35e-05	0.000171	CcSEcCtD
Trimipramine—Alopecia—Doxorubicin—hematologic cancer	4.33e-05	0.00017	CcSEcCtD
Trimipramine—Paraesthesia—Prednisone—hematologic cancer	4.32e-05	0.00017	CcSEcCtD
Trimipramine—Pruritus—Triamcinolone—hematologic cancer	4.31e-05	0.000169	CcSEcCtD
Trimipramine—Ill-defined disorder—Epirubicin—hematologic cancer	4.28e-05	0.000168	CcSEcCtD
Trimipramine—Convulsion—Methotrexate—hematologic cancer	4.27e-05	0.000168	CcSEcCtD
Trimipramine—Vomiting—Etoposide—hematologic cancer	4.27e-05	0.000168	CcSEcCtD
Trimipramine—Agitation—Epirubicin—hematologic cancer	4.24e-05	0.000167	CcSEcCtD
Trimipramine—Dyspepsia—Prednisone—hematologic cancer	4.24e-05	0.000166	CcSEcCtD
Trimipramine—Rash—Etoposide—hematologic cancer	4.23e-05	0.000166	CcSEcCtD
Trimipramine—Dermatitis—Etoposide—hematologic cancer	4.23e-05	0.000166	CcSEcCtD
Trimipramine—Headache—Etoposide—hematologic cancer	4.21e-05	0.000165	CcSEcCtD
Trimipramine—Decreased appetite—Prednisone—hematologic cancer	4.18e-05	0.000164	CcSEcCtD
Trimipramine—Dysgeusia—Doxorubicin—hematologic cancer	4.18e-05	0.000164	CcSEcCtD
Trimipramine—Rash—Prednisolone—hematologic cancer	4.18e-05	0.000164	CcSEcCtD
Trimipramine—Dermatitis—Prednisolone—hematologic cancer	4.17e-05	0.000164	CcSEcCtD
Trimipramine—Malaise—Epirubicin—hematologic cancer	4.16e-05	0.000163	CcSEcCtD
Trimipramine—Fatigue—Prednisone—hematologic cancer	4.15e-05	0.000163	CcSEcCtD
Trimipramine—Headache—Prednisolone—hematologic cancer	4.15e-05	0.000163	CcSEcCtD
Trimipramine—Discomfort—Methotrexate—hematologic cancer	4.14e-05	0.000163	CcSEcCtD
Trimipramine—Constipation—Prednisone—hematologic cancer	4.11e-05	0.000162	CcSEcCtD
Trimipramine—Promethazine—ABCB1—hematologic cancer	4.09e-05	0.021	CrCbGaD
Trimipramine—Palpitations—Epirubicin—hematologic cancer	4.07e-05	0.00016	CcSEcCtD
Trimipramine—Confusional state—Methotrexate—hematologic cancer	4.05e-05	0.000159	CcSEcCtD
Trimipramine—Doxepin—ABCB1—hematologic cancer	4.05e-05	0.0207	CrCbGaD
Trimipramine—Dizziness—Triamcinolone—hematologic cancer	4.03e-05	0.000158	CcSEcCtD
Trimipramine—Methadone—ABCB1—hematologic cancer	4.03e-05	0.0206	CrCbGaD
Trimipramine—Vision blurred—Doxorubicin—hematologic cancer	4.02e-05	0.000158	CcSEcCtD
Trimipramine—Convulsion—Epirubicin—hematologic cancer	4e-05	0.000157	CcSEcCtD
Trimipramine—Nausea—Etoposide—hematologic cancer	3.99e-05	0.000157	CcSEcCtD
Trimipramine—Hypertension—Epirubicin—hematologic cancer	3.98e-05	0.000156	CcSEcCtD
Trimipramine—Feeling abnormal—Prednisone—hematologic cancer	3.97e-05	0.000156	CcSEcCtD
Trimipramine—Asthenia—Betamethasone—hematologic cancer	3.96e-05	0.000156	CcSEcCtD
Trimipramine—Asthenia—Dexamethasone—hematologic cancer	3.96e-05	0.000156	CcSEcCtD
Trimipramine—Ill-defined disorder—Doxorubicin—hematologic cancer	3.96e-05	0.000156	CcSEcCtD
Trimipramine—Thrombocytopenia—Methotrexate—hematologic cancer	3.94e-05	0.000155	CcSEcCtD
Trimipramine—Nausea—Prednisolone—hematologic cancer	3.93e-05	0.000155	CcSEcCtD
Trimipramine—Agitation—Doxorubicin—hematologic cancer	3.92e-05	0.000154	CcSEcCtD
Trimipramine—Anxiety—Epirubicin—hematologic cancer	3.91e-05	0.000154	CcSEcCtD
Trimipramine—Pruritus—Betamethasone—hematologic cancer	3.91e-05	0.000154	CcSEcCtD
Trimipramine—Pruritus—Dexamethasone—hematologic cancer	3.91e-05	0.000154	CcSEcCtD
Trimipramine—Discomfort—Epirubicin—hematologic cancer	3.88e-05	0.000152	CcSEcCtD
Trimipramine—Vomiting—Triamcinolone—hematologic cancer	3.87e-05	0.000152	CcSEcCtD
Trimipramine—Malaise—Doxorubicin—hematologic cancer	3.85e-05	0.000151	CcSEcCtD
Trimipramine—Rash—Triamcinolone—hematologic cancer	3.84e-05	0.000151	CcSEcCtD
Trimipramine—Dry mouth—Epirubicin—hematologic cancer	3.84e-05	0.000151	CcSEcCtD
Trimipramine—Dermatitis—Triamcinolone—hematologic cancer	3.84e-05	0.000151	CcSEcCtD
Trimipramine—Anorexia—Methotrexate—hematologic cancer	3.83e-05	0.000151	CcSEcCtD
Trimipramine—Urticaria—Prednisone—hematologic cancer	3.82e-05	0.00015	CcSEcCtD
Trimipramine—Headache—Triamcinolone—hematologic cancer	3.81e-05	0.00015	CcSEcCtD
Trimipramine—Body temperature increased—Prednisone—hematologic cancer	3.8e-05	0.00015	CcSEcCtD
Trimipramine—Abdominal pain—Prednisone—hematologic cancer	3.8e-05	0.00015	CcSEcCtD
Trimipramine—Confusional state—Epirubicin—hematologic cancer	3.79e-05	0.000149	CcSEcCtD
Trimipramine—Diarrhoea—Dexamethasone—hematologic cancer	3.78e-05	0.000149	CcSEcCtD
Trimipramine—Diarrhoea—Betamethasone—hematologic cancer	3.78e-05	0.000149	CcSEcCtD
Trimipramine—Palpitations—Doxorubicin—hematologic cancer	3.77e-05	0.000148	CcSEcCtD
Trimipramine—Oedema—Epirubicin—hematologic cancer	3.76e-05	0.000148	CcSEcCtD
Trimipramine—Hypotension—Methotrexate—hematologic cancer	3.76e-05	0.000148	CcSEcCtD
Trimipramine—Desipramine—ABCB1—hematologic cancer	3.71e-05	0.019	CrCbGaD
Trimipramine—Convulsion—Doxorubicin—hematologic cancer	3.7e-05	0.000145	CcSEcCtD
Trimipramine—Thrombocytopenia—Epirubicin—hematologic cancer	3.68e-05	0.000145	CcSEcCtD
Trimipramine—Hypertension—Doxorubicin—hematologic cancer	3.68e-05	0.000145	CcSEcCtD
Trimipramine—Tachycardia—Epirubicin—hematologic cancer	3.67e-05	0.000144	CcSEcCtD
Trimipramine—Dizziness—Betamethasone—hematologic cancer	3.65e-05	0.000144	CcSEcCtD
Trimipramine—Dizziness—Dexamethasone—hematologic cancer	3.65e-05	0.000144	CcSEcCtD
Trimipramine—Insomnia—Methotrexate—hematologic cancer	3.64e-05	0.000143	CcSEcCtD
Trimipramine—Anxiety—Doxorubicin—hematologic cancer	3.62e-05	0.000142	CcSEcCtD
Trimipramine—Nausea—Triamcinolone—hematologic cancer	3.62e-05	0.000142	CcSEcCtD
Trimipramine—Paraesthesia—Methotrexate—hematologic cancer	3.61e-05	0.000142	CcSEcCtD
Trimipramine—Discomfort—Doxorubicin—hematologic cancer	3.59e-05	0.000141	CcSEcCtD
Trimipramine—Anorexia—Epirubicin—hematologic cancer	3.59e-05	0.000141	CcSEcCtD
Trimipramine—Somnolence—Methotrexate—hematologic cancer	3.57e-05	0.000141	CcSEcCtD
Trimipramine—Dry mouth—Doxorubicin—hematologic cancer	3.55e-05	0.00014	CcSEcCtD
Trimipramine—Dyspepsia—Methotrexate—hematologic cancer	3.54e-05	0.000139	CcSEcCtD
Trimipramine—Hypotension—Epirubicin—hematologic cancer	3.52e-05	0.000138	CcSEcCtD
Trimipramine—Vomiting—Betamethasone—hematologic cancer	3.51e-05	0.000138	CcSEcCtD
Trimipramine—Vomiting—Dexamethasone—hematologic cancer	3.51e-05	0.000138	CcSEcCtD
Trimipramine—Confusional state—Doxorubicin—hematologic cancer	3.51e-05	0.000138	CcSEcCtD
Trimipramine—Decreased appetite—Methotrexate—hematologic cancer	3.5e-05	0.000137	CcSEcCtD
Trimipramine—Rash—Betamethasone—hematologic cancer	3.48e-05	0.000137	CcSEcCtD
Trimipramine—Rash—Dexamethasone—hematologic cancer	3.48e-05	0.000137	CcSEcCtD
Trimipramine—Oedema—Doxorubicin—hematologic cancer	3.48e-05	0.000137	CcSEcCtD
Trimipramine—Dermatitis—Dexamethasone—hematologic cancer	3.48e-05	0.000137	CcSEcCtD
Trimipramine—Dermatitis—Betamethasone—hematologic cancer	3.48e-05	0.000137	CcSEcCtD
Trimipramine—Fatigue—Methotrexate—hematologic cancer	3.47e-05	0.000136	CcSEcCtD
Trimipramine—Headache—Betamethasone—hematologic cancer	3.46e-05	0.000136	CcSEcCtD
Trimipramine—Headache—Dexamethasone—hematologic cancer	3.46e-05	0.000136	CcSEcCtD
Trimipramine—Asthenia—Prednisone—hematologic cancer	3.45e-05	0.000136	CcSEcCtD
Trimipramine—Thrombocytopenia—Doxorubicin—hematologic cancer	3.41e-05	0.000134	CcSEcCtD
Trimipramine—Pruritus—Prednisone—hematologic cancer	3.4e-05	0.000134	CcSEcCtD
Trimipramine—Insomnia—Epirubicin—hematologic cancer	3.4e-05	0.000134	CcSEcCtD
Trimipramine—Tachycardia—Doxorubicin—hematologic cancer	3.4e-05	0.000134	CcSEcCtD
Trimipramine—Paraesthesia—Epirubicin—hematologic cancer	3.38e-05	0.000133	CcSEcCtD
Trimipramine—Somnolence—Epirubicin—hematologic cancer	3.35e-05	0.000132	CcSEcCtD
Trimipramine—Anorexia—Doxorubicin—hematologic cancer	3.32e-05	0.00013	CcSEcCtD
Trimipramine—Chlorpromazine—ALB—hematologic cancer	3.32e-05	0.017	CrCbGaD
Trimipramine—Feeling abnormal—Methotrexate—hematologic cancer	3.31e-05	0.00013	CcSEcCtD
Trimipramine—Dyspepsia—Epirubicin—hematologic cancer	3.31e-05	0.00013	CcSEcCtD
Trimipramine—Diarrhoea—Prednisone—hematologic cancer	3.29e-05	0.000129	CcSEcCtD
Trimipramine—Nausea—Dexamethasone—hematologic cancer	3.28e-05	0.000129	CcSEcCtD
Trimipramine—Nausea—Betamethasone—hematologic cancer	3.28e-05	0.000129	CcSEcCtD
Trimipramine—Amitriptyline—ALB—hematologic cancer	3.28e-05	0.0168	CrCbGaD
Trimipramine—Decreased appetite—Epirubicin—hematologic cancer	3.27e-05	0.000129	CcSEcCtD
Trimipramine—Hypotension—Doxorubicin—hematologic cancer	3.25e-05	0.000128	CcSEcCtD
Trimipramine—Fatigue—Epirubicin—hematologic cancer	3.24e-05	0.000128	CcSEcCtD
Trimipramine—Constipation—Epirubicin—hematologic cancer	3.22e-05	0.000126	CcSEcCtD
Trimipramine—Urticaria—Methotrexate—hematologic cancer	3.19e-05	0.000126	CcSEcCtD
Trimipramine—Dizziness—Prednisone—hematologic cancer	3.18e-05	0.000125	CcSEcCtD
Trimipramine—Abdominal pain—Methotrexate—hematologic cancer	3.18e-05	0.000125	CcSEcCtD
Trimipramine—Body temperature increased—Methotrexate—hematologic cancer	3.18e-05	0.000125	CcSEcCtD
Trimipramine—Chlorpromazine—ABCB1—hematologic cancer	3.17e-05	0.0162	CrCbGaD
Trimipramine—Insomnia—Doxorubicin—hematologic cancer	3.15e-05	0.000124	CcSEcCtD
Trimipramine—Imipramine—ABCB1—hematologic cancer	3.15e-05	0.0161	CrCbGaD
Trimipramine—Amitriptyline—ABCB1—hematologic cancer	3.13e-05	0.016	CrCbGaD
Trimipramine—Paraesthesia—Doxorubicin—hematologic cancer	3.13e-05	0.000123	CcSEcCtD
Trimipramine—Feeling abnormal—Epirubicin—hematologic cancer	3.1e-05	0.000122	CcSEcCtD
Trimipramine—Somnolence—Doxorubicin—hematologic cancer	3.1e-05	0.000122	CcSEcCtD
Trimipramine—Dyspepsia—Doxorubicin—hematologic cancer	3.07e-05	0.00012	CcSEcCtD
Trimipramine—Vomiting—Prednisone—hematologic cancer	3.06e-05	0.00012	CcSEcCtD
Trimipramine—Rash—Prednisone—hematologic cancer	3.03e-05	0.000119	CcSEcCtD
Trimipramine—Dermatitis—Prednisone—hematologic cancer	3.03e-05	0.000119	CcSEcCtD
Trimipramine—Decreased appetite—Doxorubicin—hematologic cancer	3.03e-05	0.000119	CcSEcCtD
Trimipramine—Headache—Prednisone—hematologic cancer	3.01e-05	0.000118	CcSEcCtD
Trimipramine—Fatigue—Doxorubicin—hematologic cancer	3e-05	0.000118	CcSEcCtD
Trimipramine—Urticaria—Epirubicin—hematologic cancer	2.99e-05	0.000118	CcSEcCtD
Trimipramine—Constipation—Doxorubicin—hematologic cancer	2.98e-05	0.000117	CcSEcCtD
Trimipramine—Abdominal pain—Epirubicin—hematologic cancer	2.97e-05	0.000117	CcSEcCtD
Trimipramine—Body temperature increased—Epirubicin—hematologic cancer	2.97e-05	0.000117	CcSEcCtD
Trimipramine—Asthenia—Methotrexate—hematologic cancer	2.89e-05	0.000113	CcSEcCtD
Trimipramine—Feeling abnormal—Doxorubicin—hematologic cancer	2.87e-05	0.000113	CcSEcCtD
Trimipramine—Nausea—Prednisone—hematologic cancer	2.86e-05	0.000112	CcSEcCtD
Trimipramine—Pruritus—Methotrexate—hematologic cancer	2.85e-05	0.000112	CcSEcCtD
Trimipramine—Urticaria—Doxorubicin—hematologic cancer	2.77e-05	0.000109	CcSEcCtD
Trimipramine—Abdominal pain—Doxorubicin—hematologic cancer	2.75e-05	0.000108	CcSEcCtD
Trimipramine—Body temperature increased—Doxorubicin—hematologic cancer	2.75e-05	0.000108	CcSEcCtD
Trimipramine—Diarrhoea—Methotrexate—hematologic cancer	2.75e-05	0.000108	CcSEcCtD
Trimipramine—Asthenia—Epirubicin—hematologic cancer	2.7e-05	0.000106	CcSEcCtD
Trimipramine—Pruritus—Epirubicin—hematologic cancer	2.66e-05	0.000105	CcSEcCtD
Trimipramine—Dizziness—Methotrexate—hematologic cancer	2.66e-05	0.000105	CcSEcCtD
Trimipramine—Diarrhoea—Epirubicin—hematologic cancer	2.57e-05	0.000101	CcSEcCtD
Trimipramine—Vomiting—Methotrexate—hematologic cancer	2.56e-05	0.000101	CcSEcCtD
Trimipramine—Rash—Methotrexate—hematologic cancer	2.54e-05	9.97e-05	CcSEcCtD
Trimipramine—Dermatitis—Methotrexate—hematologic cancer	2.53e-05	9.96e-05	CcSEcCtD
Trimipramine—Headache—Methotrexate—hematologic cancer	2.52e-05	9.9e-05	CcSEcCtD
Trimipramine—Asthenia—Doxorubicin—hematologic cancer	2.5e-05	9.82e-05	CcSEcCtD
Trimipramine—Dizziness—Epirubicin—hematologic cancer	2.49e-05	9.78e-05	CcSEcCtD
Trimipramine—Pruritus—Doxorubicin—hematologic cancer	2.46e-05	9.68e-05	CcSEcCtD
Trimipramine—Vomiting—Epirubicin—hematologic cancer	2.39e-05	9.41e-05	CcSEcCtD
Trimipramine—Nausea—Methotrexate—hematologic cancer	2.39e-05	9.39e-05	CcSEcCtD
Trimipramine—Diarrhoea—Doxorubicin—hematologic cancer	2.38e-05	9.36e-05	CcSEcCtD
Trimipramine—Rash—Epirubicin—hematologic cancer	2.37e-05	9.33e-05	CcSEcCtD
Trimipramine—Dermatitis—Epirubicin—hematologic cancer	2.37e-05	9.32e-05	CcSEcCtD
Trimipramine—Headache—Epirubicin—hematologic cancer	2.36e-05	9.27e-05	CcSEcCtD
Trimipramine—Dizziness—Doxorubicin—hematologic cancer	2.3e-05	9.05e-05	CcSEcCtD
Trimipramine—Nausea—Epirubicin—hematologic cancer	2.24e-05	8.79e-05	CcSEcCtD
Trimipramine—Vomiting—Doxorubicin—hematologic cancer	2.21e-05	8.7e-05	CcSEcCtD
Trimipramine—Rash—Doxorubicin—hematologic cancer	2.2e-05	8.63e-05	CcSEcCtD
Trimipramine—Dermatitis—Doxorubicin—hematologic cancer	2.19e-05	8.62e-05	CcSEcCtD
Trimipramine—Headache—Doxorubicin—hematologic cancer	2.18e-05	8.57e-05	CcSEcCtD
Trimipramine—Nausea—Doxorubicin—hematologic cancer	2.07e-05	8.13e-05	CcSEcCtD
Trimipramine—DRD2—Signaling Pathways—CDKN1B—hematologic cancer	2.33e-06	2.21e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—HRAS—hematologic cancer	2.33e-06	2.21e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—PTEN—hematologic cancer	2.33e-06	2.21e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—EP300—hematologic cancer	2.32e-06	2.2e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—PIK3CA—hematologic cancer	2.32e-06	2.2e-05	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—AKT1—hematologic cancer	2.31e-06	2.19e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—PTEN—hematologic cancer	2.3e-06	2.18e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—PIK3CA—hematologic cancer	2.3e-06	2.18e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CDKN1B—hematologic cancer	2.3e-06	2.18e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CDKN1B—hematologic cancer	2.29e-06	2.17e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—VEGFA—hematologic cancer	2.29e-06	2.17e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MDM2—hematologic cancer	2.29e-06	2.17e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—HRAS—hematologic cancer	2.29e-06	2.17e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CASP3—hematologic cancer	2.29e-06	2.17e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—IL2—hematologic cancer	2.28e-06	2.17e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—CREBBP—hematologic cancer	2.28e-06	2.16e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MAPK8—hematologic cancer	2.28e-06	2.16e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—AKT1—hematologic cancer	2.27e-06	2.16e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—IL6—hematologic cancer	2.27e-06	2.16e-05	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—AKT1—hematologic cancer	2.27e-06	2.15e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—SRC—hematologic cancer	2.27e-06	2.15e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—STAT3—hematologic cancer	2.27e-06	2.15e-05	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—AKT1—hematologic cancer	2.27e-06	2.15e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.26e-06	2.15e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—NRAS—hematologic cancer	2.26e-06	2.15e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—SRC—hematologic cancer	2.26e-06	2.14e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CASP3—hematologic cancer	2.25e-06	2.13e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CDKN1B—hematologic cancer	2.25e-06	2.13e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—IL2—hematologic cancer	2.25e-06	2.13e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CASP3—hematologic cancer	2.25e-06	2.13e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.24e-06	2.13e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—IL2—hematologic cancer	2.24e-06	2.13e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—TP53—hematologic cancer	2.24e-06	2.12e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—IL6—hematologic cancer	2.24e-06	2.12e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—IL6—hematologic cancer	2.23e-06	2.12e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—CREBBP—hematologic cancer	2.23e-06	2.11e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CCND1—hematologic cancer	2.23e-06	2.11e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MTOR—hematologic cancer	2.23e-06	2.11e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PIK3CB—hematologic cancer	2.23e-06	2.11e-05	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—AKT1—hematologic cancer	2.22e-06	2.11e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—EP300—hematologic cancer	2.22e-06	2.11e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—JUN—hematologic cancer	2.22e-06	2.11e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—VEGFA—hematologic cancer	2.21e-06	2.1e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CASP3—hematologic cancer	2.2e-06	2.09e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—IL2—hematologic cancer	2.2e-06	2.09e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—VEGFA—hematologic cancer	2.2e-06	2.09e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—EP300—hematologic cancer	2.19e-06	2.08e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CCND1—hematologic cancer	2.19e-06	2.08e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—IL6—hematologic cancer	2.19e-06	2.08e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—STAT3—hematologic cancer	2.19e-06	2.08e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—JUN—hematologic cancer	2.19e-06	2.07e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CCND1—hematologic cancer	2.19e-06	2.07e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—NRAS—hematologic cancer	2.18e-06	2.07e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—JUN—hematologic cancer	2.18e-06	2.07e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—STAT3—hematologic cancer	2.18e-06	2.07e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—NRAS—hematologic cancer	2.17e-06	2.06e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.17e-06	2.06e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—MAPK3—hematologic cancer	2.17e-06	2.05e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PIK3CD—hematologic cancer	2.16e-06	2.05e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—SRC—hematologic cancer	2.16e-06	2.05e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CDKN1A—hematologic cancer	2.15e-06	2.04e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—PTEN—hematologic cancer	2.15e-06	2.04e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CCND1—hematologic cancer	2.15e-06	2.03e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—HRAS—hematologic cancer	2.14e-06	2.03e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—JUN—hematologic cancer	2.14e-06	2.03e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—ALB—hematologic cancer	2.14e-06	2.03e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—HRAS—hematologic cancer	2.13e-06	2.02e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CDKN1A—hematologic cancer	2.12e-06	2.01e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CDKN1A—hematologic cancer	2.11e-06	2.01e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—PTEN—hematologic cancer	2.11e-06	2.01e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PIK3CD—hematologic cancer	2.11e-06	2e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—PTEN—hematologic cancer	2.11e-06	2e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—MYC—hematologic cancer	2.11e-06	2e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—VEGFA—hematologic cancer	2.11e-06	2e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MAPK8—hematologic cancer	2.1e-06	1.99e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—TGFB1—hematologic cancer	2.1e-06	1.99e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.1e-06	1.99e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—AKT1—hematologic cancer	2.1e-06	1.99e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—MAPK3—hematologic cancer	2.09e-06	1.98e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CDKN1B—hematologic cancer	2.09e-06	1.98e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—ALB—hematologic cancer	2.09e-06	1.98e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—STAT3—hematologic cancer	2.08e-06	1.98e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.08e-06	1.97e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—MAPK3—hematologic cancer	2.08e-06	1.97e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—NRAS—hematologic cancer	2.08e-06	1.97e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CDKN1A—hematologic cancer	2.08e-06	1.97e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—PTEN—hematologic cancer	2.07e-06	1.96e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MAPK8—hematologic cancer	2.07e-06	1.96e-05	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—AKT1—hematologic cancer	2.07e-06	1.96e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MAPK8—hematologic cancer	2.06e-06	1.96e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—AKT1—hematologic cancer	2.06e-06	1.96e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—AKT1—hematologic cancer	2.06e-06	1.95e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.05e-06	1.95e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—IL6—hematologic cancer	2.05e-06	1.94e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—EP300—hematologic cancer	2.05e-06	1.94e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CASP3—hematologic cancer	2.05e-06	1.94e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—IL2—hematologic cancer	2.04e-06	1.94e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PIK3R1—hematologic cancer	2.04e-06	1.94e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—IL6—hematologic cancer	2.03e-06	1.93e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—MYC—hematologic cancer	2.03e-06	1.93e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—TGFB1—hematologic cancer	2.03e-06	1.92e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MAPK8—hematologic cancer	2.03e-06	1.92e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—MYC—hematologic cancer	2.02e-06	1.92e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—AKT1—hematologic cancer	2.02e-06	1.92e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—TGFB1—hematologic cancer	2.02e-06	1.91e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—EP300—hematologic cancer	2.02e-06	1.91e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—EP300—hematologic cancer	2.01e-06	1.91e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.99e-06	1.89e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.99e-06	1.89e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.99e-06	1.89e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CCND1—hematologic cancer	1.99e-06	1.89e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—SRC—hematologic cancer	1.99e-06	1.89e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MAPK3—hematologic cancer	1.99e-06	1.89e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.99e-06	1.89e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—JUN—hematologic cancer	1.99e-06	1.89e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—EP300—hematologic cancer	1.97e-06	1.87e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.97e-06	1.87e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—ALB—hematologic cancer	1.96e-06	1.86e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—SRC—hematologic cancer	1.96e-06	1.86e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—SRC—hematologic cancer	1.96e-06	1.86e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—ALB—hematologic cancer	1.95e-06	1.85e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—KRAS—hematologic cancer	1.95e-06	1.85e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—VEGFA—hematologic cancer	1.94e-06	1.84e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MYC—hematologic cancer	1.94e-06	1.84e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—TGFB1—hematologic cancer	1.93e-06	1.83e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CDKN1A—hematologic cancer	1.93e-06	1.83e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PTEN—hematologic cancer	1.92e-06	1.82e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—STAT3—hematologic cancer	1.92e-06	1.82e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—SRC—hematologic cancer	1.92e-06	1.82e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—NRAS—hematologic cancer	1.92e-06	1.82e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—VEGFA—hematologic cancer	1.91e-06	1.81e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—VEGFA—hematologic cancer	1.91e-06	1.81e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—AKT1—hematologic cancer	1.89e-06	1.79e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—STAT3—hematologic cancer	1.89e-06	1.79e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—STAT3—hematologic cancer	1.89e-06	1.79e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—NRAS—hematologic cancer	1.89e-06	1.79e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.89e-06	1.79e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—NRAS—hematologic cancer	1.88e-06	1.79e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MAPK8—hematologic cancer	1.88e-06	1.78e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.88e-06	1.78e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—KRAS—hematologic cancer	1.88e-06	1.78e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—AKT1—hematologic cancer	1.88e-06	1.78e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—VEGFA—hematologic cancer	1.87e-06	1.77e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—KRAS—hematologic cancer	1.87e-06	1.77e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.86e-06	1.77e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—STAT3—hematologic cancer	1.85e-06	1.76e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—NRAS—hematologic cancer	1.85e-06	1.75e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.84e-06	1.75e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MAPK3—hematologic cancer	1.84e-06	1.74e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—EP300—hematologic cancer	1.83e-06	1.74e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MAPK3—hematologic cancer	1.81e-06	1.71e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MAPK3—hematologic cancer	1.8e-06	1.71e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—KRAS—hematologic cancer	1.79e-06	1.7e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—PIK3CA—hematologic cancer	1.79e-06	1.7e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MYC—hematologic cancer	1.79e-06	1.69e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—SRC—hematologic cancer	1.78e-06	1.69e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—TGFB1—hematologic cancer	1.78e-06	1.69e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MAPK3—hematologic cancer	1.77e-06	1.68e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.76e-06	1.67e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MYC—hematologic cancer	1.76e-06	1.67e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MYC—hematologic cancer	1.75e-06	1.66e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—TGFB1—hematologic cancer	1.75e-06	1.66e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—TGFB1—hematologic cancer	1.75e-06	1.66e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—VEGFA—hematologic cancer	1.74e-06	1.65e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.73e-06	1.65e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—TP53—hematologic cancer	1.73e-06	1.64e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—PIK3CA—hematologic cancer	1.73e-06	1.64e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MYC—hematologic cancer	1.72e-06	1.63e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—STAT3—hematologic cancer	1.72e-06	1.63e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.72e-06	1.63e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—PIK3CA—hematologic cancer	1.72e-06	1.63e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—TGFB1—hematologic cancer	1.72e-06	1.63e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—NRAS—hematologic cancer	1.72e-06	1.63e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—TP53—hematologic cancer	1.67e-06	1.58e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—TP53—hematologic cancer	1.66e-06	1.58e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—HRAS—hematologic cancer	1.65e-06	1.57e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—KRAS—hematologic cancer	1.65e-06	1.56e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—PIK3CA—hematologic cancer	1.64e-06	1.56e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MAPK3—hematologic cancer	1.64e-06	1.56e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PTEN—hematologic cancer	1.63e-06	1.55e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—KRAS—hematologic cancer	1.62e-06	1.54e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—PIK3CA—hematologic cancer	1.62e-06	1.54e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—KRAS—hematologic cancer	1.62e-06	1.54e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MYC—hematologic cancer	1.6e-06	1.52e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—HRAS—hematologic cancer	1.6e-06	1.51e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—TGFB1—hematologic cancer	1.59e-06	1.51e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PTEN—hematologic cancer	1.59e-06	1.51e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—TP53—hematologic cancer	1.59e-06	1.51e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—KRAS—hematologic cancer	1.59e-06	1.51e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—HRAS—hematologic cancer	1.59e-06	1.51e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—IL6—hematologic cancer	1.58e-06	1.5e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—EP300—hematologic cancer	1.55e-06	1.47e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—IL6—hematologic cancer	1.53e-06	1.45e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—HRAS—hematologic cancer	1.52e-06	1.44e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—IL6—hematologic cancer	1.52e-06	1.44e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—EP300—hematologic cancer	1.52e-06	1.44e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—PIK3CA—hematologic cancer	1.52e-06	1.44e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PTEN—hematologic cancer	1.5e-06	1.42e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—PIK3CA—hematologic cancer	1.49e-06	1.41e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—PIK3CA—hematologic cancer	1.49e-06	1.41e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PTEN—hematologic cancer	1.49e-06	1.41e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.48e-06	1.4e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—KRAS—hematologic cancer	1.48e-06	1.4e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—TP53—hematologic cancer	1.47e-06	1.39e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—AKT1—hematologic cancer	1.46e-06	1.39e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—PIK3CA—hematologic cancer	1.46e-06	1.39e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—IL6—hematologic cancer	1.46e-06	1.38e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—TP53—hematologic cancer	1.44e-06	1.37e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—TP53—hematologic cancer	1.44e-06	1.37e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—EP300—hematologic cancer	1.43e-06	1.36e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—EP300—hematologic cancer	1.42e-06	1.34e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—TP53—hematologic cancer	1.41e-06	1.34e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—AKT1—hematologic cancer	1.41e-06	1.34e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—AKT1—hematologic cancer	1.4e-06	1.33e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—HRAS—hematologic cancer	1.4e-06	1.33e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—HRAS—hematologic cancer	1.38e-06	1.31e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—HRAS—hematologic cancer	1.38e-06	1.31e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.37e-06	1.3e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PIK3CA—hematologic cancer	1.36e-06	1.29e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—HRAS—hematologic cancer	1.35e-06	1.28e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—AKT1—hematologic cancer	1.34e-06	1.27e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—IL6—hematologic cancer	1.34e-06	1.27e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—AKT1—hematologic cancer	1.33e-06	1.26e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—IL6—hematologic cancer	1.32e-06	1.25e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—IL6—hematologic cancer	1.32e-06	1.25e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—TP53—hematologic cancer	1.31e-06	1.25e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.3e-06	1.23e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—IL6—hematologic cancer	1.29e-06	1.23e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—ALB—hematologic cancer	1.28e-06	1.22e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—HRAS—hematologic cancer	1.26e-06	1.19e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—AKT1—hematologic cancer	1.24e-06	1.17e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.23e-06	1.17e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—AKT1—hematologic cancer	1.22e-06	1.16e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—AKT1—hematologic cancer	1.22e-06	1.15e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—IL6—hematologic cancer	1.2e-06	1.14e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—AKT1—hematologic cancer	1.19e-06	1.13e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.15e-06	1.09e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.13e-06	1.08e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.12e-06	1.06e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—AKT1—hematologic cancer	1.11e-06	1.05e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.06e-06	1e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.05e-06	9.94e-06	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PTEN—hematologic cancer	9.8e-07	9.3e-06	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—AKT1—hematologic cancer	9.39e-07	8.91e-06	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—EP300—hematologic cancer	9.35e-07	8.86e-06	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—AKT1—hematologic cancer	9.17e-07	8.69e-06	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—AKT1—hematologic cancer	8.64e-07	8.19e-06	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—AKT1—hematologic cancer	8.57e-07	8.12e-06	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	6.91e-07	6.56e-06	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—AKT1—hematologic cancer	5.65e-07	5.36e-06	CbGpPWpGaD
